<DOC>
	<DOC>NCT02118376</DOC>
	<brief_summary>GLP-1 receptor agonists promote fat redistribution in obese women with type 2 diabetes, reduce liver fat content, improve the inflammation state</brief_summary>
	<brief_title>Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status</brief_title>
	<detailed_description>As a treatment for type 2 diabetesGlucagon like peptide -1 (Glucan-like peptide-1, GLP-1) receptor agonists plays the role of promoting insulin secretion, inhibiting glucagon secretionï¼Œand also has the central and peripheral effects,it can inhibit appetite,reduce weight.GLP-1 receptor agonists promote fat redistribution in obese women with type 2 diabetes, reduce liver fat content, improve the inflammation state</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Clinical diagnosis of overweight and type 2 diabetes mellitus Poor body condition (severe liver and kidney dysfunction) Unknown causes of pancreatitis, chronic pancreatitis, pancreatic resection, stomach operation, malignant tumor, previous use of systemic corticosteroids (local or inhalation of exceptions) heart function or niacin, incomplete serious endocrine disease genetic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>obesity; fat distribution; inflammation</keyword>
</DOC>